Press Releases :: Aurinia Pharmaceuticals Inc. (AUPH)

September 2, 2015 • 9:00 am EDT

Aurinia Pharmaceuticals to Present at the 2015 Rodman & Renshaw 17th Annual Global Investment Conference

August 11, 2015 • 5:15 pm EDT

Aurinia Reports Second Quarter 2015 Financial Results

August 6, 2015 • 9:00 am EDT

Aurinia Pharmaceuticals to Present at the Canaccord Genuity 35th Annual Growth Conference

May 27, 2015 • 5:58 pm EDT

Aurinia Announces Results of Annual General Meeting

May 19, 2015 • 2:14 pm EDT

Aurinia Pharmaceuticals to Present at the 2015 UBS Global Health Care Conference

May 15, 2015 • 5:00 pm EDT

Aurinia Reports First Quarter 2015 Financial Results and Restatement of 2014 Financial Statements

April 23, 2015 • 5:07 pm EDT

Aurinia Pharmaceuticals to Host Lupus Nephritis Opinion Leader Meeting and Webcast on May 5 in New York

March 30, 2015 • 5:24 pm EDT

Aurinia Reports Fourth Quarter and Full Year 2014 Financial Results and Highlights Initiation of Its Open Label Clinical Study to Investigate the Impact of Voclosporin on Lupus Nephritis Biomarkers

March 6, 2015 • 7:00 pm EST

Aurinia Announces Change to Its Board of Directors

February 26, 2015 • 6:08 pm EST

Aurinia Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care Conference

Select a page:

rss_feed News RSS

©2025 Aurinia Pharmaceuticals Inc. All Rights Reserved. US-LUP-2300105 08/23